Search research articles
Contact Us
Filters
Showing results (121-130 of 144) with videos related to
Page
of 15
Sort By:
International Journal of Cancer
|
August 23, 2023
Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies
Naoya Kemmotsu, Kiichiro Ninomiya, Kei Kunimasa, et al.
Plos One
|
November 15, 2022
Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study
Tatsuya Nishikawa, Takako Inoue, Tomoyuki Otsuka, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 5, 2020
Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction
Kei Kunimasa, Toru Oka, Satoshi Hara, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 19, 2021
Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection
Takako Inoue, Yui Funatsu, Masaya Ohnishi, et al.
Cancer Science
|
February 25, 2024
Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study
Masahiro Morise, Terufumi Kato, Shingo Matsumoto, et al.
Plos One
|
February 14, 2022
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B
Yoshihito Nagura, Kentaro Matsuura, Etsuko Iio, et al.
Thoracic Cancer
|
September 13, 2022
Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single-center retrospective study
Kei Kunimasa, Naotoshi Sugimoto, Takahisa Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 30, 2020
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis
Masanori Furukawa, Kei Moriya, Jiro Nakayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 3, 2022
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation
Takanori Suzuki, Kentaro Matsuura, Kenji Urakabe, et al.
Journal of Gastroenterology and Hepatology
|
June 29, 2024
Serum interleukin-6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis
Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 144) with videos related to
Sort By:
Page
of 15
International Journal of Cancer
|
August 23, 2023
Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies
Naoya Kemmotsu, Kiichiro Ninomiya, Kei Kunimasa, et al.
Plos One
|
November 15, 2022
Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study
Tatsuya Nishikawa, Takako Inoue, Tomoyuki Otsuka, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 5, 2020
Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction
Kei Kunimasa, Toru Oka, Satoshi Hara, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 19, 2021
Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection
Takako Inoue, Yui Funatsu, Masaya Ohnishi, et al.
Cancer Science
|
February 25, 2024
Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study
Masahiro Morise, Terufumi Kato, Shingo Matsumoto, et al.
Plos One
|
February 14, 2022
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B
Yoshihito Nagura, Kentaro Matsuura, Etsuko Iio, et al.
Thoracic Cancer
|
September 13, 2022
Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single-center retrospective study
Kei Kunimasa, Naotoshi Sugimoto, Takahisa Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 30, 2020
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis
Masanori Furukawa, Kei Moriya, Jiro Nakayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 3, 2022
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation
Takanori Suzuki, Kentaro Matsuura, Kenji Urakabe, et al.
Journal of Gastroenterology and Hepatology
|
June 29, 2024
Serum interleukin-6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis
Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, et al.
Page
of 15